Filing Details

Accession Number:
0001209191-12-029489
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-21 13:00:00
Reporting Period:
2012-05-21
Filing Date:
2012-05-21
Accepted Time:
2012-05-21 16:39:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405288 A Jacqualyn Fouse C/o Celgene Corporation
86 Morris Avenue
Summit NJ 07901
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-21 1,000 $68.92 9,085 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 247 Indirect 401(k) Plan
Footnotes
  1. Reflects 247 additional shares deposited by the company in connection with its matching contribution to the reporting persons 401(k) plan account on March 28, 2012.